Method

NOVEL TECHNOLOGIES

OncoCellMDx has developed a technology to compare immunogenomic profiles in various oncology and non-oncology based indications … [Learn More]

INITIALLY TARGETING CANCER

OncoCellMDx’s Proprietary Technology has been extensively studied in Prostate Cancer with additional focus in other cancers … [Learn More]

OTHER INDICATIONS

Pilot studies have been performed in several other oncology and non-oncology based indications including metabolic disease, autoimmune disease, neurological disorders, cardiac disease among several others.